Related Experiment Videos
Intracerebroventricular administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its metabolite
Neuropharmacology
|June 1, 1985
Abstract:
We found that both MPTP and its metabolite MPP+ decrease dopamine and increase acetylcholine content of mouse neostriatum when administered intracerebroventricularly (ICV). These observations support the notion that MPP+ may be the active neurotoxin formed in brain after MPTP administration. They also suggest that cholinergic mechanisms may be a target of the neurotoxin.
Insights
MPTP and its metabolite MPP+ reduce dopamine and increase acetylcholine in mouse brains. This suggests MPP+ is the active neurotoxin and cholinergic pathways are a potential target.
Area of Science:
- Neuroscience
- Neuropharmacology
- Toxicology
Background:
- MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) is a neurotoxin known to induce Parkinsonism.
- The precise mechanism and active metabolite of MPTP neurotoxicity are subjects of ongoing research.
Purpose of the Study:
- To investigate the effects of MPTP and its metabolite MPP+ (1-methyl-4-phenylpyridinium) on neurotransmitter levels in the mouse neostriatum.
- To determine if MPP+ is the primary neurotoxic agent responsible for MPTP-induced neurochemical changes.
Main Methods:
- Administration of MPTP and MPP+ via intracerebroventricular (ICV) injection in mice.
- Measurement of dopamine and acetylcholine content in the mouse neostriatum.
Main Results:
- Both MPTP and MPP+ administration led to a decrease in dopamine content.
- Both MPTP and MPP+ administration resulted in an increase in acetylcholine content in the neostriatum.
- The observed neurochemical alterations were consistent with MPTP and MPP+ acting as neurotoxins.
Conclusions:
- MPP+ is likely the active neurotoxin formed in the brain following MPTP administration.
- Cholinergic mechanisms in the brain may be a significant target of MPTP/MPP+ neurotoxicity.